[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Phase 3 Open Label Study to Evaluate the Long-term Safety and Tolerability of ALKS 8700 in Adults with Relapsing Remitting Multiple Sclerosis

What is the purpose of the study?

The purpose of this research study is to test the long-term safety and treatment effect of ALKS 8700 in subjects who have relapsing-remitting MS.

Upstate Institutional Review Board (IRB) Number:

1032689

Study/Protocol ID:

ALK8700-A301

Study Phase:

Phase III

Patient Age Group:

Adults

Principal Investigator:

Corey A McGraw

Who can I contact for more information?

Name: Muhammad M Iqbal
Phone: 315-464-1814
Email: iqbalmuh@upstate.edu

Return to Previous Page || Search Again

Top